Human Reproduction Update, Vol.7, No.4 pp.363-369, 2001
© European Society of Human Reproduction and Embryology 2001; all rights reserved
Testicular function following chemotherapy
1 Department of Endocrinology, Christie Hospital NHS Trust, Manchester, UK
To whom correspondence should be addressed at: S. M. Shalet, Department of Endocrinology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 4BX, UK. e-mail: stephen.m.shalet{at}man.ac.uk
Abstract
Testicular dysfunction is a common long-term sequela of cytotoxic chemotherapy used in the treatment of many malignancies. The degree to which testicular function is affected is dose- and agent-dependent. The impact on germinal epithelial function of standard multi-agent regimens used in the treatment of lymphomas has been widely studied. Procarbazine-containing regimens result in azoospermia in the vast majority of patients, but much lesser degrees of long-term gonadotoxicity are apparent with the newer forms of chemotherapy. High-dose chemotherapy used as preparation before bone marrow transplant is also associated with irreversible germinal epithelial failure in the majority of men. Treatment of testicular cancer with cisplatin and carboplatin regimens leads to temporary azoo- and oligozoospermia in most men, with a recovery to normospermia in 80% by 5 years. There is also evidence of mild Leydig cell impairment in a proportion of men treated with cytotoxic agents, although the clinical significance of this is not clear. Several methods of preserving testicular function during potentially sterilizing treatment have been considered. At present, sperm banking remains the only proven method, although hormonal manipulation to enhance recovery of spermatogenesis and cryopreservation of testicular germ cells are possibilities for the future.
Key words: chemotherapy / enhancement of spermatogenesis / sperm banking / testicular cancer / testicular function
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.P. Ginsberg, C.A. Carlson, K. Lin, W.L. Hobbie, E. Wigo, X. Wu, R.L. Brinster, and T.F. Kolon An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: a report of acceptability and safety Hum. Reprod., October 27, 2009; (2009) dep371v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. O. Ilbey, E. Ozbek, A. Simsek, M. Cekmen, A. Otunctemur, and A. Somay Chemoprotective Effect of a Nuclear Factor-{kappa}B Inhibitor, Pyrrolidine Dithiocarbamate, Against Cisplatin-Induced Testicular Damage in Rats J Androl, September 1, 2009; 30(5): 505 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Carmely, D. Meirow, A. Peretz, M. Albeck, B. Bartoov, and B. Sredni Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice Hum. Reprod., June 1, 2009; 24(6): 1322 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Jeruss and T. K. Woodruff Preservation of Fertility in Patients with Cancer N. Engl. J. Med., February 26, 2009; 360(9): 902 - 911. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Geens, E. Goossens, G. De Block, L. Ning, D. Van Saen, and H. Tournaye Autologous spermatogonial stem cell transplantation in man: current obstacles for a future clinical application Hum. Reprod. Update, March 1, 2008; 14(2): 121 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. van Beek, M. Smit, M. M. van den Heuvel-Eibrink, F. H. de Jong, F. G. Hakvoort-Cammel, C. van den Bos, H. van den Berg, R. F.A. Weber, R. Pieters, and S. M.P.F. de Muinck Keizer-Schrama Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood Hum. Reprod., December 1, 2007; 22(12): 3215 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Bieber, L. Marcon, B. F. Hales, and B. Robaire Effects of Chemotherapeutic Agents for Testicular Cancer on the Male Rat Reproductive System, Spermatozoa, and Fertility J Androl, March 1, 2006; 27(2): 189 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Wagner, K. Beier, E. Christen, G. A. Hollander, and W. Krenger Leydig cell injury as a consequence of an acute graft-versus-host reaction Blood, April 1, 2005; 105(7): 2988 - 2990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Fossa, H. Magelssen, K. Melve, A. B. Jacobsen, F. Langmark, and R. Skjaerven Parenthood in Survivors After Adulthood Cancer and Perinatal Health in Their Offspring: A Preliminary Report J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 77 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sawhney, C. J. Giammona, M. L. Meistrich, and J. H. Richburg Cisplatin-Induced Long-term Failure of Spermatogenesis in Adult C57/Bl/6J Mice J Androl, January 1, 2005; 26(1): 136 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Raptopoulou, P. Sidiropoulos, and D. T Boumpas Ovarian failure and strategies for fertility preservation in patients with systemic lupus erythematosus Lupus, December 1, 2004; 13(12): 887 - 890. [PDF]
|
|
|
|
|
|
A. Kamischke, H. Jurgens, L. Hertle, W. E. Berdel, and E. Nieschlag Cryopreservation of Sperm From Adolescents and Adults With Malignancies J Androl, July 1, 2004; 25(4): 586 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shinohara, K. Inoue, N. Ogonuki, M. Kanatsu-Shinohara, H. Miki, K. Nakata, M. Kurome, H. Nagashima, S. Toyokuni, K. Kogishi, et al. Birth of offspring following transplantation of cryopreserved immature testicular pieces and in-vitro microinsemination Hum. Reprod., December 1, 2002; 17(12): 3039 - 3045. [Abstract] [Full Text] [PDF]
|
|